Chien-Yu Chiu
Overview
Explore the profile of Chien-Yu Chiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li P, Liao M, Cheng P, Liang J, Liu I, Chiu C, et al.
PLoS Negl Trop Dis
. 2024 Mar;
18(3):e0012031.
PMID: 38478493
[This corrects the article DOI: 10.1371/journal.pntd.0001636.].
2.
Chiu C, Chung T, Chen S, Ma Y
Int J Nanomedicine
. 2019 Jul;
14:4767-4780.
PMID: 31308657
Background: Magnetic nanoparticles (MNPs) can be localized against hemodynamic forces in blood vessels with the application of an external magnetic field. In addition, PEGylation of nanoparticles may increase the half-life...
3.
Tang Y, Liu I, Li P, Chiu C, Lin C, Huang C, et al.
Am J Trop Med Hyg
. 2017 Jul;
97(4):1049-1061.
PMID: 28749765
Dengue virus (DENV) circulates in tropical and subtropical areas around the world, where it causes high morbidity and mortality. There is no effective treatment of infection, with supportive care being...
4.
Tang Y, Chiu C, Lin C, Huang C, Chen Y, Destura R, et al.
Int J Mol Sci
. 2015 Nov;
16(11):27850-64.
PMID: 26610481
Dengue virus (DENV) infection is currently at pandemic levels, with populations in tropical and subtropical regions at greatest risk of infection. Early diagnosis and management remain the cornerstone for good...
5.
Tang C, Liao M, Chiu C, Shen W, Chiu C, Cheng P, et al.
PLoS One
. 2015 Aug;
10(8):e0136328.
PMID: 26309127
The four serotypes of dengue virus (DENV1-4) pose a serious threat to global health. Cross-reactive and non-neutralizing antibodies enhance viral infection, thereby exacerbating the disease via antibody-dependent enhancement (ADE). Studying...
6.
Lu R, Chen M, Chang D, Chiu C, Lin W, Yan S, et al.
PLoS One
. 2013 Jun;
8(6):e66128.
PMID: 23776619
Targeted delivery of drugs to tumors represents a significant advance in cancer diagnosis and therapy. Therefore, development of novel tumor-specific ligands or pharmaceutical nanocarriers is highly desirable. In this study,...
7.
Li P, Liao M, Cheng P, Liang J, Liu I, Chiu C, et al.
PLoS Negl Trop Dis
. 2012 May;
6(5):e1636.
PMID: 22563515
Background: Dengue virus (DENV) is a significant public health threat in tropical and subtropical regions of the world. A therapeutic antibody against the viral envelope (E) protein represents a promising...
8.
Liu I, Chiu C, Chen Y, Wu H
J Biol Chem
. 2011 Jan;
286(11):9726-36.
PMID: 21233208
The pathogenesis of dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), both serious complications of dengue virus (DV) infection, remains unclear. In this study, we found that anti-DV NS1 (nonstructural...
9.
Lu T, Kao C, Lin C, Huang D, Chiu C, Huang Y, et al.
J Cell Biochem
. 2009 Jul;
108(1):315-25.
PMID: 19565568
The identification of molecules that are down-regulated in malignant phenotype is important for understanding tumor biology and their role in tumor suppression. We compared the expression profile of four normal...
10.
Chang D, Chiu C, Kuo S, Lin W, Lo A, Wang Y, et al.
J Biol Chem
. 2009 Mar;
284(19):12905-16.
PMID: 19276080
It is known that solid tumors recruit new blood vessels to support tumor growth, but the molecular diversity of receptors in tumor angiogenic vessels might also be used clinically to...